(MedPage Today) — The FDA on Friday approved chenodiol (Ctexli) for the treatment of cerebrotendinous xanthomatosis (CTX) in adults.
Chenodiol — a naturally occurring human bile acid also known as chenodeoxycholic acid — is the first FDA…
Source link : https://www.medpagetoday.com/publichealthpolicy/fdageneral/114332
Author :
Publish date : 2025-02-21 22:02:53
Copyright for syndicated content belongs to the linked Source.
